Back to Khiron or All Oil Concentrates

Details provided are based upon best-known information made available to MedBud, please reconfirm with your pharmacy. This page was last updated:
MedBud typically only updates products when availability changes, or new information is provided. An availability status from several months ago can still be valid when a product remains in/out of stock, or has been discontinued.

Dosing Look-Up Table (Estimated)

0.01/g1.2/mg THC1.4/mg CBD
0.05/g6/mg THC7/mg CBD
0.1/g12/mg THC14/mg CBD
0.15/g18/mg THC21/mg CBD
0.2/g24/mg THC28/mg CBD
0.25/g30/mg THC35/mg CBD
0.3/g36/mg THC42/mg CBD
/gCalculate THCCalculate CBD

Please note values above are based on registered THC/CBD percentages, subject to ±10% allowed variance. Values provided are 'best case', losses to air during vaporisation or combustion will always occur.

Medication Details

Brand
Flag of Colombia Bogotá, Colombia Khiron
Designation
Khiriox T12:C14
Chemotype
Type II: THC/CBD Mix
Carrier Oil
Medium-Chain Triglycerides
THC Potential Range (±10%)
10.8-13.2mg/ml
CBD Potential Range (±10%)
12.6-15.4mg/ml
Distributor
United Kingdom Curaleaf® Laboratories
Cultivated/Produced in
Flag of North Macedonia North Macedonia
Imported by
United Kingdom Curaleaf® Laboratories

Stock Availability

We provide stock/pharmacy information only for use by medical cannabis patients, clinicians and pharmacists*.

Best-Known Status: Awaiting ETA

We try to ascertain stock status strictly based on the importer/distributor supplying pharmacies. Availability at individual pharmacies will differ.

*Cannabis is a controlled-substance and can only be legally dispensed upon submission of a valid prescription from a prescribing clinic, ordinarily listed.

Flag of Colombia Bogotá, Colombia About Khiron Europe GmbH

Khiron Logo

Khiron is a pharmaceutical company dedicated to medical cannabis, supplying high-quality flower and extract products across key European markets, including Germany and the UK. Does not cultivate directly.

Our portfolio, marketed under the Khiron and Satoline brands, is sourced through trusted international partners and produced to EU-GMP standards, ensuring full traceability, consistent quality, and reliable supply.

We focus on translating the therapeutic potential of cannabis into practical, clinically relevant treatments—particularly in areas where conventional approaches are insufficient.

khironmed.co.uk

  Information provided is partially community sourced and may be outdated or otherwise incorrect. Please report any inaccuracies found by email.

NHS LogoFurther National Health-Service Information on Cannabis-Based Products for Medicinal Use (CBPMs)